Delivery Order SPE2DR25D2209-SPE2DR26FD6HB
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Clindamycin PH 900 mg/6 ml vials with a ceiling value of $17,867.22. This firm fixed-price delivery order, which is not set-aside, will be performed at the vendor's Corporate Office in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The contract represents a routine pharmaceutical procurement under the defense medical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Clindamycin PH 900 mg/6 ml vials totaling $1,242.18 under a firm fixed-price arrangement. This non-set-aside competitive award is scheduled for completion by October 15, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,234.84 to AmerisourceBergen Drug Corp for the supply of Clindamycin 900 mg/50 mL in 50 mL vials. This is a firm fixed price delivery order with an ultimate completion date of September 29, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Clindamycin 600 mg/50 ml in D5W solution with a ceiling value of $1,210.80 and an ultimate completion date of September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $2,321.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Clindamycin 60ML on November 10, 2025, with an ultimate completion date of November 12, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement executed under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,439.16 for the supply of Clindamycin 900 mg/50 mL in dextrose 5% water solution on August 21, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 22, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Clindamycin PH 1% Solution in 60ML units, with a contract value of $5,685.56. This non-competitive delivery order was awarded on September 24, 2025, with an ultimate completion date of September 25, 2025, and is structured as a firm fixed price contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Clindamycin PH 1% Solution in 60ml quantities, valued at $2,454.60 with completion targeted for November 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under...
- The Defense Logistics Agency awarded a $2,117.43 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Clindamycin 900 mg/50 mL in dextrose 5% water solution. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by September 16, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Clindamycin 900 mg/50 ml in dextrose 5% water (D5W) solution on October 28, 2025, with a ceiling value of $1,892.94 and ultimate completion date of October 29, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and represents a pharmaceutical supply fulfillment under the company's broader federal medical procurement portfolio. The product will...
- SPE2DR25D2209Indefinite Delivery Contract
- SPE2DR25D2209-SPE2DR26FD6HBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Clindamycin PH 900 mg/6 ml vials with a ceiling value of $1,311.28. This is a firm fixed price delivery order with an ultimate completion date of November 21, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling the supply of a broad range of medications, vaccines, medical devices, and healthcare supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/20/25 |